Cerepar en es it fr

Cerepar Brand names, Cerepar Analogs

Cerepar Brand Names Mixture

  • No information avaliable

Cerepar Chemical_Formula

C26H28N2

Cerepar RX_link

No information avaliable

Cerepar fda sheet

Cerepar msds (material safety sheet)

Cerepar Synthesis Reference

No information avaliable

Cerepar Molecular Weight

368.514 g/mol

Cerepar Melting Point

No information avaliable

Cerepar H2O Solubility

750 mg/L

Cerepar State

Solid

Cerepar LogP

5.63

Cerepar Dosage Forms

No information avaliable

Cerepar Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Cerepar Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Cerepar Absorption

No information avaliable

Cerepar side effects and Toxicity

No information avaliable

Cerepar Patient Information

No information avaliable

Cerepar Organisms Affected

Humans and other mammals